TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients (Q38482216)

3 September 2017

TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients (English)

1 reference

3 September 2017

1 reference

Kyoungbun Lee

1

1 reference

3 September 2017

Ji Youn Chae

2

1 reference

3 September 2017

Cheol Kwak

3

1 reference

3 September 2017

Ja Hyeon Ku

4

1 reference

3 September 2017

Kyung Chul Moon

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

30 August 2010

1 reference

3 September 2017

1 reference

3 September 2017

76

1 reference

3 September 2017

5

1 reference

3 September 2017

1268.e7-13

1 reference

Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.06.010

10.1016/J.UROLOGY.2010.06.010

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference